Epic Sciences has appointed Greg Lucier as chairman of its board of directors. Lucier was previously chairman and CEO of Life Technologies. He joins Epic as the company focuses on commercializing its circulating rare cell analysis platform, including products and services to detect circulating tumor cells.
Verisante this week named Kenneth Beer and Philip Werschler to its clinical advisory board.
Beer is a Florida-based dermatologist and a volunteer assistant professor at the University of Miami and a consulting associate with the Department of Medicine at Duke University.
Werschler is a dermatologist and skin cancer surgeon and an expert in medical and cosmetic dermatology.